Skip to main content

Trust centre

Trust is a record, not a badge.

Read each NEUVIOR record with its source class, date, scope, accountable authority, review state and visible limitation intact.

Request relevant evidence contextRead the evidence boundary

EVIDENCE CHAIN

A public claim cannot outrun its record.

  1. 01Attributable source

    Named record, repository or issuing authority

  2. 02Scoped record

    Entity, period, purpose and limitations retained

  3. 03Accountable review

    Named owner and visible review state

PUBLIC CLAIM≤VERIFIED RECORD SCOPE

Source, scope and accountable review remain connected. Missing evidence remains unknown.
EVIDENCE RECORDS · DATED · SCOPEDPublication rule | Unknown remains unknownProduct status updated 20 July 2026

HOW TO READ TRUST

The evidence type controls the claim.

Company, project, product, source and assurance records answer different questions. Their scope and limitations stay visible.

01

SOURCE PROVENANCE

Representative provenance record

Each record keeps the source, scope, review state and limitation together.

Record class
Named record class
Source or repository
Named public source or controlled repository
Date or period
Visible date or period
Entity and scope
Named entity and bounded scope
Accountable owner or authority
Named owner or issuing authority
Receipt and review state
Visible receipt or review state
Visible limitation
What the record does not establish

02

EVIDENCE MAP

Six evidence classes

  1. Company identity and legal record

    Which legal entity and company record is being checked?

  2. Exact public funding and project record

    What does the exact public project record establish?

  3. Product status and assurance record

    What is the dated product state, and which assurance remains separate?

  4. Source provenance and capability evidence

    Which source supports the capability, and what remains unproved?

  5. Security and data governance record

    Which security or data governance question is in scope?

  6. Future intent

    What is direction rather than current capability?

Funding does not become deployment; a repository does not become a running service; and doctrine does not become assurance completion.

DATED PRODUCT STATUS

Current public product state

PHARMORIS is under controlled development and is not in production. It is designed for staff workflows with human control. See the dated product status record for the current evidence boundary.

No NHS deployment, approval, certification, realised saving or patient outcome is claimed.

Classified public record

Open the classified public record

ANALYSIS + EVIDENCE BOUNDARY

Read the argument. Verify the product separately.

Published analysis can explain why governance matters. It cannot evidence security, clinical authority, certification, product readiness or local approval. Use the dated NEUVIOR records for that.

  1. AI Ethics Now / University of Warwick IATLPodcast appearance

    AI and Accountability: When Does a Suggestion Become a Decision?

    Varun Sharma joins AI Ethics Now to examine false confidence, human responsibility and the point where AI assisted suggestions become accountable decisions.

    Hear where an AI suggestion becomes a decision
  2. TechRadar ProContributed opinion

    Five questions to test whether an AI stack is truly under your control

    In TechRadar Pro, Varun Sharma sets out five tests for enterprise AI control across provenance, infrastructure, legal authority and safe exit.

    Test provenance, control and safe exit
  3. NEUVIOR InsightsNEUVIOR analysis

    From pilot theatre to financial grip: how NHS CFOs should evaluate AI in medicines optimisation

    NHS finance leaders do not need another AI pitch. They need a disciplined way to decide whether a technology can release value within the financial rules they are already being held to.

    See how a finance leader should test an AI claim
Read the governance arguments

NEUVIOR Insights and After Publication reflections are company or founder analysis. Publisher records evidence publication, not endorsement, adoption, product readiness, savings or clinical outcomes.

Make the next step useful

Bring the problem that needs a clearer decision.

Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.

Request relevant evidence contextSpeak with NEUVIOR

CLAIM CHECK

Five fields travel with the record.

Source
Attributable
Date
Visible
Scope
Bounded
Owner
Accountable
Limit
Explicit
Unknown remains unknown until an appropriate record closes the gap.

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01What is NEUVIOR?

NEUVIOR is a pharmaceutical company registered in Scotland. It is building capabilities across medicines intelligence, governed technology and longer term development. PHARMORIS is its immediate product priority.

02What does NEUVIOR build today?

NEUVIOR is developing PHARMORIS, a human-governed medicines operations system in controlled, non-production development. It is intended to connect evidence, decisions, accountable work and value review. No independent TRL, deployment, customer adoption or clinical validation is claimed.

03What is PHARMORIS by NEUVIOR?

PHARMORIS is a configurable medicines operations system under controlled development. It is designed to help authorised teams progress medicine opportunities from evidence linked to its source, through an owned ActionCase, a human decision, delivery and review.

04Who founded NEUVIOR?

Varun Sharma is the Founder, CEO and CTO of NEUVIOR and leads the company and PHARMORIS product architecture.

05Where does NEUVIOR have a presence?

NEUVIOR works across Glasgow, London and Mumbai. Glasgow is the company origin and registered Scottish base. London supports commercial activity led by the founder. Mumbai supports market engagement in India and relationships across the pharmaceutical sector. These are different forms of presence. They do not imply three registered offices or regulated facilities.